138 related articles for article (PubMed ID: 3371456)
1. Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells.
Newburg DS; Shea TB; Yatziv S; Raghavan SS; McCluer RH
Exp Mol Pathol; 1988 Jun; 48(3):317-23. PubMed ID: 3371456
[TBL] [Abstract][Full Text] [Related]
2. beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell.
Newburg DS; Yatziv S; McCluer RH; Raghavan S
Biochim Biophys Acta; 1986 Jun; 877(1):121-6. PubMed ID: 3087427
[TBL] [Abstract][Full Text] [Related]
3. Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.
Yatziv S; Newburg DS; Livni N; Barfi G; Kolodny EH
J Lab Clin Med; 1988 Apr; 111(4):416-20. PubMed ID: 3351378
[TBL] [Abstract][Full Text] [Related]
4. In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.
Prence EM; Chaturvedi P; Newburg DS
J Neurosci Res; 1996 Feb; 43(3):365-71. PubMed ID: 8714525
[TBL] [Abstract][Full Text] [Related]
5. Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.
Grabowski GA; Dinur T; Osiecki KM; Kruse JR; Legler G; Gatt S
Am J Hum Genet; 1985 May; 37(3):499-510. PubMed ID: 4003396
[TBL] [Abstract][Full Text] [Related]
6. Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages.
Das PK; Murray GJ; Gal AE; Barranger JA
Exp Cell Res; 1987 Feb; 168(2):463-74. PubMed ID: 3803450
[TBL] [Abstract][Full Text] [Related]
7. Chemical inhibition of β-glucocerebrosidase does not affect phagocytosis and early containment of Leishmania by murine macrophages.
Ribeiro H; Rocha MI; Castro H; Macedo MF
Exp Parasitol; 2020 Sep; 216():107939. PubMed ID: 32535115
[TBL] [Abstract][Full Text] [Related]
8. Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.
Schueler UH; Kolter T; Kaneski CR; Zirzow GC; Sandhoff K; Brady RO
J Inherit Metab Dis; 2004; 27(5):649-58. PubMed ID: 15669681
[TBL] [Abstract][Full Text] [Related]
9. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
Kuo CL; Kallemeijn WW; Lelieveld LT; Mirzaian M; Zoutendijk I; Vardi A; Futerman AH; Meijer AH; Spaink HP; Overkleeft HS; Aerts JMFG; Artola M
FEBS J; 2019 Feb; 286(3):584-600. PubMed ID: 30600575
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes.
Trajkovic-Bodennec S; Bodennec J; Futerman AH
Blood Cells Mol Dis; 2004; 33(1):77-82. PubMed ID: 15223015
[TBL] [Abstract][Full Text] [Related]
11. Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase alpha.
Kacher Y; Golan A; Pewzner-Jung Y; Futerman AH
Blood Cells Mol Dis; 2007; 39(1):124-9. PubMed ID: 17482853
[TBL] [Abstract][Full Text] [Related]
12. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.
Bondar C; Ormazabal M; Crivaro A; Ferreyra-Compagnucci M; Delpino MV; Rozenfeld PA; Mucci JM
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098793
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome.
Campeau PM; Rafei M; Boivin MN; Sun Y; Grabowski GA; Galipeau J
Blood; 2009 Oct; 114(15):3181-90. PubMed ID: 19587377
[TBL] [Abstract][Full Text] [Related]
14. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
Daniels LB; Glew RH; Radin NS; Vunnam RR
Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
[TBL] [Abstract][Full Text] [Related]
16. Distribution of conduritol B epoxide in the animal model for Gaucher's disease (Gaucher mouse).
Stephens MC; Bernatsky A; Singh H; Kanfer JN; Legler G
Biochim Biophys Acta; 1981 Jan; 672(1):29-32. PubMed ID: 6783121
[TBL] [Abstract][Full Text] [Related]
17. Gaucher disease in mice induced by conduritol-B-epoxide: morphologic features.
Adachi M; Volk BW
Arch Pathol Lab Med; 1977 May; 101(5):255-9. PubMed ID: 576797
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease.
van Weely S; Brandsma M; Strijland A; Tager JM; Aerts JM
Biochim Biophys Acta; 1993 Mar; 1181(1):55-62. PubMed ID: 8457606
[TBL] [Abstract][Full Text] [Related]
19. Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease.
Aerts JM; Donker-Koopman WE; Koot M; Barranger JA; Tager JM; Schram AW
Clin Chim Acta; 1986 Jul; 158(2):155-63. PubMed ID: 2943536
[TBL] [Abstract][Full Text] [Related]
20. The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase.
Pelled D; Shogomori H; Futerman AH
J Inherit Metab Dis; 2000 Mar; 23(2):175-84. PubMed ID: 10801059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]